Follow us on:

Linkedin Facebook

CVS Health Corporation – Consensus Indicates Potential 14.8% Upside

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

CVS Health Corporation found using ticker (CVS) have now 23 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 130 and 98 and has a mean target at 117.81. Now with the previous closing price of 102.58 this indicates there is a potential upside of 14.8%. The 50 day moving average now sits at 96.29 and the 200 day moving average is 98.77. The market capitalisation for the company is $134,038m. Visit the company website at: https://www.cvshealth.com

The potential market cap would be $153,939m based on the market concensus.

0

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Latest Company News

    Broker Ratings

    CVS Health Corporation – Consensus ‘buy’ rating and 29.2% Upside Potential

    Broker Ratings

    CVS Health Corporation Share Price Target ‘$68.90’, now 27.0% Upside Potential

    Broker Ratings

    CVS Health Corporation – Consensus ‘buy’ rating and 18.4% Upside Potential

    Broker Ratings

    CVS Health Corporation Share Price Target ‘$67.39’, now 20.1% Upside Potential

    Broker Ratings

    CVS Health Corporation – Consensus ‘buy’ rating and 15.7% Upside Potential

    Broker Ratings

    CVS Health Corporation – Consensus ‘buy’ rating and 3.3% Upside Potential

      Latest interviews

      View all interviews 

      Company Presentations

      View all Company Presentations

      Brokers Talk

      View all Broker Talk

      FTSE 100 News

      Search

      Search

      Green News

      View all Sustainable sectors, Plcs and news  

      Q&A's

      View all Question and Answers

      Funds

      View all Funds, Market Insights and news

      UK Broker Ratings

      Hardman & Co

      Don't Miss Our News Alerts

      Subscribe Free

      Find us on:

      Linkedin Facebook

      Useful links

      Disclaimer

      You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

      © 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.